RankingsPricing
  1. US-listed companies
  2. CONMED Corp
  3. Financials
  4. Capital expenditures

CONMED CorpCNMD

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-13-31.25%
Dec 31, 2023-19-12.64%
Dec 31, 2022-22+46.54%
Dec 31, 2021-15+14.24%
Dec 31, 2020-13-35.15%
Dec 31, 2019-20+21.56%
Dec 31, 2018-17+28.54%
Dec 31, 2017-13-12.95%
Dec 31, 2016-15-1.71%
Dec 31, 2015-15-2.61%
Dec 31, 2014-15-16.45%
Dec 31, 2013-18-14.34%
Dec 31, 2012-22+22.68%
Dec 31, 2011-18

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)